Laxxon Medical to Present Innovative Oral GLP-1 Agonist including Multi-Compartment Micro-Tablet Form at 2024 BIO-Europe Convention, Aiming to Enhance Compliance for Special Patient Groups
Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US
Investing in Safety: Laxxon Medical's QR Code Technology and the Fight Against Counterfeit Drugs
Understanding GLP-1 Medications for Diabetes and Obesity
The Controlled Release Drug Delivery Market
Revolutionizing Parkinson's Treatment: How Laxxon's Extended-Release Levodopa Improves Quality of Life
The Potential of 3D Screen Printing to Combat Counterfeit Medication
Digital Tools In the Healthcare Industry: Addressing Counterfeit Medicine and Safety
Breaking Down Obesity: Understanding Its Effects and Navigating Treatment Options
Understanding Diabetes: A Comprehensive Guide to Causes, Effects, and Modern Treatments
The Role of Patent Extensions in Healthcare: Balancing Innovation and Access
The Impact of Technology on Pharmaceutical Research: Speed, Efficiency, and Accuracy
What Is the FDA 505b2 Pathway?
Advancing medication with the right DDS: Pulsatile release
Revolutionizing Pharma: 3D Screen Printing and Smart Technologies Shaping the Future of Medicine
Advancing medication with the right DDS: Immediate and delayed release
Legally Protecting Inventions and Innovations Related to the Medical Field
3D Screen Printing is Transforming Drug Manufacturing and Improving Patient Experiences
What is First Pass Metabolism?
Medication Errors Are On The Rise